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OBJECTIVE: To evaluate the costs and patient safety of a pilot implementation of an automated dispensing
cabinet in a critical care unit of a private tertiary hospital in Sa˜o Paulo/Brazil.
METHODS: This study considered pre- (January-August 2013) and post- (October 2013-October 2014) intervention
periods. We considered the time and cost of personnel, number of adverse events, audit adjustments to patient
bills, and urgent requests and returns of medications to the central pharmacy. Costs were evaluated based on a
5-year analytical horizon and are reported in Brazilian Reals (R$) and US dollars (USD).
RESULTS: The observed decrease in the mean number of events reported with regard to the automated drug-
dispensing system between pre- and post-implementation periods was not significant. Importantly, the
numbers are small, which limits the power of the mean comparative analysis between the two periods.
A reduction in work time was observed among the nurses and administrative assistants, whereas pharmacist
assistants showed an increased work load that resulted in an overall 6.5 hours of work saved/day and a
reduction of R$ 33,598 (USD 14,444) during the first year. The initial investment (R$ 206,065; USD 88,592) would
have been paid off in 5 years considering only personnel savings. Other findings included significant reductions
of audit adjustments to patient hospital bills and urgent requests and returns of medications to the central
pharmacy.
CONCLUSIONS: Evidence of the positive impact of this technology on personnel time and costs and on other
outcomes of interest is important for decision making by health managers.
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’ INTRODUCTION
Healthcare-related errors are common (1). In the United
States between 2000 and 2002, 37 million admissions occur-
red in the Medicare system, and 1.14 million patient safety-
related incidents were reported. In an extrapolation to all
admissions in American hospitals during this period, 575,000
preventable deaths would result from patient safety-related
incidents (2).
A German study addressing three public hospitals, total-
ing 1,208 beds and 49,462 patients showed that the mean
cost of patients (n 1,891) who suffered an adverse drug
event (ADE) was h5,113-h10,059. The mean hospital stay
of patients with an ADE was 2.9 days longer than that of
patients without an ADE. An extrapolation for the entire
country estimates that ADEs entail a total annual cost of
h1.058 billion (3).
A prospective observational study found that 61% (170/
277) of serious medical errors – which cause or have the
potential to cause damage or injury – are drug prescription
or administration errors (4). Another prospective observa-
tional study of intensive care reported one error, resulting in
a potential or actual ADE, for every 5 prescription items
administered (5).
The occurrence of drug prescription errors is 7%, affecting
2% of patients/day and 50% of hospital admissions (6).
Conversely, a systematic review indicated that approximately
10% of errors involving drugs corresponded to administration
errors (7).
In Brazil, a prospective cohort study, which was conducted
in a tertiary teaching hospital with blinded nursing staff,
found that 21% (238/1,119) of the doses of drugs prescribed
and dispensed by the pharmacy were not administered (8).
The application of information technology to healthcare
has increased the safety of hospital prescription and admini-
stration procedures. Computerized physician order-entry
systems with a drug menu standardized by the hospital
institution, a clinical decision support system, and electronicDOI: 10.6061/clinics/2017(10)07
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medication administration record are key tools for patient
drug safety (9,10).
Automated dispensing devices (ADDs) are increasingly
present in healthcare organizations. The transition of the
pharmaceutical profession to direct patient care, changes in
healthcare systems and cost-reduction pressures have pro-
moted the use of ADDs. The American Society of Health-
System Pharmacists (ASHP) approves the use of automated
drug distribution because the system frees pharmacists from
labor-intensive distribution functions. Those pharmacists
then begin to share responsibility for drug inventory with
nurses, which improves the accuracy and timeliness of drug
availability and enhances patient care (11).
A recent systematic review showed that ADDs decrease
drug storage errors and increase resource management effi-
ciency. The nursing staff spent significantly less time manag-
ing controlled drugs. The results related to other drugs are
inconclusive. Similarly, there was no clear evidence that these
devices reduced drug errors resulting in patient harm, increa-
sed nursing or pharmacy staff time spent on patient care or
reduced hospital costs (12).
Although the literature indicates a high usage rate of this
technology in tertiary hospitals within developed countries,
studies specifically addressing ADDs in Brazilian hospitals
remain scarce.
This study was conducted to assess the economic and
patient-safety impact of the implementation of the Pyxiss
automated materials and drug-dispensing system in an
inpatient unit for critically and semi-critically ill patients in
a tertiary hospital.
’ METHODS
Study site, period and design
The study was conducted at ‘‘Hospital Sírio-Libanês’’
(HSL), which is a private, tertiary hospital that has 368 beds,
including 44 intensive care beds; averages 18,840 admissions
per year; and is located in São Paulo, Brazil. The hospital
pharmacy department consists of a central pharmacy, 23
storage units, and 5 satellite pharmacies located in the follow-
ing specific hospital units: the oncology unit, the emergency
room, the surgery unit, the intensive care unit, and the diagno-
stic and imaging center. The hospital adopted an individual
medication order-distribution system. The oncology depart-
ment and the main intensive care unit used the unit-dose
system.
The Pyxiss ADD system was gradually introduced at
HSL units in São Paulo from 2013 to 2015, primarily to
promote drug-use safety by integrating drug prescription
with dispensing. This new technology was also expected to
reduce the time spent by the nursing and administrative staff
on managing the inventory of the drug room and to improve
urgent care performance. Improvements in the quality of
patient billing (through the adequate invoicing of drugs and
disposable medical supplies in the unit) and stock accuracy
to reduce inventory adjustments were also expected.
The effect of introducing the ADD system for the storage
and control of the peripheral stock located in an 11-bed unit
housing semi-critically and critically ill patients was assessed.
Clinical and cost outcomes were assessed with cost outcomes
considering a 5-year analytical horizon starting in 2013.
The characterization of the central pharmacy regarding the
products administered, the products dispensed, and the
number of professionals in 2013 is outlined in Table 1.
Intervention
The Pyxiss ADD system was pilot-deployed at an HSL
unit in September 2013.
The unit in which the Pyxiss was implemented consisted
of eleven cardiology beds, including seven semi-critical beds
and four intensive care beds. The demographic characteriza-
tions of the unit in the periods before (January-August 2013)
and after (October 2013-October 2014) the introduction of the
ADD system were similar.
Drug dispensing via the HSL pharmacy was performed
using a hybrid model. Regularly prescribed drugs were
dispensed by the central pharmacy. Drugs and disposable
materials used during the first hours of patient admis-
sion as well as those that are used because of changes
in drug prescriptions were dispensed from the periphe-
ral stock located within each care unit. Each care unit also
had a cart stocked with drugs and materials for emergency
care.
The patient profile and medical specialties of the care unit
determined the composition of the drugs and disposable
materials in this peripheral stock. The quantity of each
product was based on the historical quantitative consump-
tion provided by the hospital information system.
The products were barcoded to ensure the traceability,
stock write-off, and invoicing of the drugs and materials
included in the peripheral stocks.
The peripheral stock structure changed significantly with
the implementation of the ADD system. Previously, products
were placed in conventional cabinets in the drug room in the
care unit, and only controlled drugs were stored in lockable
drawers (13). The other products were stored in various
places, according to the convenience of the team managing
the stock. Resupply was performed once per day and was
automatically generated by the hospital information system.
Electronic prescription was not integrated with this stock,
which together with the possibility of introducing or remov-
ing products from cabinets without a mandatory barcode
reading, led to the need for many inventory adjustments and
increased potential error. Administrative processes (invoi-
cing, stock write-off for resupply and control, and key pro-
cedures in drug use safety) depended on the adherence of the
nursing staff (who were directed to access the hospital
information system using a password) to select the patient
and perform the barcode reading of each product.
Table 1 - Characterization of the Central Pharmacy of Hospital
Sı´rio-Libaneˆs regarding the products administered and dispensed
as well as the number of staff. 2013. Sa˜o Paulo, Brazil.
Characteristic Monthly mean (number)
Products administered 1,994,973
Products dispensed 270,421
Professionals Number of professionals
Pharmaceutical manager 1
Pharmacy coordinators 4
Materials supervisors 5
Pharmacists 35
Pharmacy technicians 11
Pharmacy assistants 102
Messengers 12
Assistants and administrative assistants 38
Trainees 4
Young apprentices 1
Total 213
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After introducing the ADD system, the peripheral stock
began to be placed inside the device within the care unit,
resulting in a centralized, organized, and closed stock. Resup-
ply, which was automatically generated by the hospital infor-
mation system, began to be performed twice daily and was
monitored by the team of pharmacy assistants to ensure
organization according to the record of each product in the
dispensing system. Electronic prescriptions were integrated
with the dispensing system with biometric control of stock
access for all users and privileges according to professional
category. From that time forward, the nursing team had
access to only the drugs prescribed for each patient. Emer-
gency drugs, such as those not reviewed by the pharmacist
and not part of the patient’s profile, were removed only by a
nurse who was previously authorized to execute an override
order. Then, the patient and the drugs were selected based on
time, and each compartment containing the drug or material
opened only for the practitioner to remove the products from
the dispensing system after all of these steps were completed.
After closing each compartment, the system invoiced the
patient and adjusted the inventory. No change was intro-
duced regarding the control of product expiration dates,
which was performed monthly by the pharmacy team.
Data analysis
The following outcomes were considered in the analysis:
number of ADEs, audit adjustments to invoicing of materials
and drugs in patient bills, performance in meeting urgent
requests, need for central pharmacy services and product
returns from the unit to the central pharmacy.
According to the World Health Organization, an ADE is a
patient injury resulting from a medication, either because of
a pharmacological reaction to a normal dose or because of a
preventable adverse reaction to a drug resulting from an
error (14). Data concerning ADEs were collected from the
HSL information system, which stored the details of each
event notification, including the date, place, type of occur-
rence, drug involved, phase of the process, classification, and
degree and type of resulting harm. Events that occurred in
the unit during the study period were analyzed. Events that
occurred during the drug prescription and transcription
phases were disregarded. The events were categorized by
phase of the process (dispensing or administration) and
harm classification. Harm to patients was classified in accor-
dance with the World Health Organization International
Classification for Patient Safety. Mild harm was character-
ized as an event that results in mild symptoms, loss of
function, and minimal or intermediate damage, albeit short-
lived, without need for major intervention or requiring
minimal intervention (observation, investigation, review, or
minimal treatment). Moderate harm was characterized as
an event resulting in symptoms that required intervention
(additional surgical procedure or therapeutic treatment),
prolonged hospital stay, permanent long-term damage or
loss of function. Severe harm was defined as a symptomatic
event requiring life-saving intervention or a major surgical/
medical intervention, shortened life expectancy, or major
permanent or long-term harm or loss of function.
The time spent by the healthcare professionals involved in
the drug and material management process of the care unit
was assessed directly by measuring the work time of each
activity and healthcare professional involved. This measure-
ment was performed before and after implementing the
ADD system. This assessment was performed by a pharma-
cist who was an HSL pharmacy coordinator.
The working time was then estimated as hours per day
spent on each activity. The cost per hour of work for each
professional category was estimated from the gross monthly
salary (including the benefits paid by the hospital), consider-
ing a weekly load of 40 hours. In addition, 30% pay for vaca-
tion and a 1 month salary bonus at the end of every working
year (i.e., a 13th paycheck) were used to estimate annual
salary because these benefits are paid by the hospital per
Brazilian legislation. The working time per day was multi-
plied by the number of days in a year to estimate the annual
economic impact. The total annual time (in hours) was multi-
plied by the salary per hour of work resulting in the annual
costs for personnel by professional category. Personnel costs
during the period before the implementation of the ADD
system were then compared with personnel costs during the
period after the implementation of the ADD system.
The periods pre- and post-introduction of the automated
drug-dispensing system were considered January to August
2013 and October 2013 to October 2014, respectively, for all
outcomes.
Categorical data are described and expressed as absolute
(n) and relative (%) frequencies. Continuous variables are
described as the mean and standard deviation. Unpaired
Student’s t-test was used to compare the means of conti-
nuous variables with normal distributions. Pearson’s chi-
squared test was used to compare ratios. The significance
level was set at 0.05 for all tests. The data were tabulated and
analyzed using Microsoft Excel 2010 and SPSS for Windows,
version 22.
Direct medical costs, including the investment costs for
implementing the Pyxiss ADD system and human resource
costs, were considered in the cost analysis. All costs were
expressed as Brazilian Reals (R$) and converted to US
Dollars (USD) considering the official exchange rate in
December 2013 (1 BRL=0.43 USD). To estimate the annual
cost of human resources for future years (2014-2017), the
estimated annual savings resulting from averted costs for
human resource salaries for 2013 were then adjusted for
inflation considering the Brazilian annual national consumer
price index (15) according to the salary-adjustment proce-
dures adopted by the hospital. The following annual cumula-
tive national consumer price indices were used: 5.56% for
2013, 6.23% for 2014, 11.28% for 2015, and 6.58% for 2016.
The rate of medical equipment depreciation was set at
10% per year, assuming a useful life of 10 years, according to
current Brazilian law (16).
The study was reviewed by the Institutional Review Board,
which waived the need for approval.
’ RESULTS
Number of events
During the study period, a total of 37 ADEs were reported
in the unit. Most (n=31, 83.8%) adverse events occurred
during the drug-dispensing phase, whereas the other events
(n=6, 16.2%) occurred during the drug administration phase.
Although a decrease in the mean number of events reported
was observed between the ADD system pre- (2.25±2.19
events/month) and post-implementation (1.46±1.39 events/
month) periods, this difference was not significant (p=0.32). The
same trend was also observed when assessing the events that
occurred during drug dispensing (1.88 versus 1.23, p=0.34) and
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administration (0.38 versus 0.23, p=0.65) separately. It is
worth noting that the numbers are very small, thus limiting
the power of the comparative analysis of means between
the two periods.
Audit adjustments to hospital bills
The number of audit adjustments to the hospital bill of
each hospitalized patient was analyzed regarding the
inclusion or exclusion of materials and drugs administered.
We observed a significant decrease in adjustments to
drug inclusions and exclusions and material inclusions.
A decrease in material exclusions also occurred, although
this change was not significant (Table 2).
Product requests and returns to the central
pharmacy
A significant decrease (by 71%) in urgent requests was
observed after implementing the ADD system when asses-
sing the number of requests and the need for central
pharmacy services during both periods (Table 3). Similarly,
the number of products returned to the central pharmacy
decreased significantly (by 30%) during the ADD system
post-implementation period. The observed 15% decrease in
routine requests was not significant.
Healthcare professional time
The implementation of the ADD system resulted in a
change in the distribution of the time and type of healthcare
professionals involved in drug management activities (Table 4).
The time spent on activities performed by nurses and admi-
nistrative assistants decreased, whereas the time spent on
activities performed by pharmacy assistants increased, result-
ing in a total reduction of 6.5 work hours per day (Table 4).
Nursing time was devoted primarily to drug inventory
activities, including counting controlled drugs and perform-
ing stock write-offs, which significantly decreased after the
implementation of the ADD system. Administrative assistant
time, which also decreased, was primarily devoted to count-
ing drugs and materials and resupplying items (Figure 1).
Stock inventory and item resupply activities, which were
performed by the stock room supervisor and administrative
assistants, respectively, began to be performed by another
professional, i.e., the pharmacy assistant.
Costs
The total cost of the Pyxiss ADD system included the
cost of the device (R$ 198,065.88; USD 85,153) and costs
associated with cabinet-making and remodeling services
(R$ 8,000.00; USD 3,439.40). Information technology (IT) costs
Table 2 - Audit adjustments to material and medication invoicing in the Advanced Heart Failure Unit of Hospital Sı´rio-Libaneˆs before
and after implementing the automated medication dispensing system. 2013-2014. Sa˜o Paulo, Brazil.
Type of product Procedure requested Conventional dispensing period Automated dispensing period Variation (%) p-value
by the audit Mean Standard deviation Mean Standard deviation
Drugs Inclusion (mean/month) 1,215.75 815.49 555.08 210.49 -54.30 0.01
Exclusion (mean/month) 1,635.13 451.19 1,036.92 297.21 -36.60 o0.01
Materials Inclusion (mean/month) 1,061.25 668.20 461.54 151.72 -56.50 o0.01
Exclusion (mean/month) 3,008.75 1,425.01 2,255.15 786.20 -25.10 0.13
Table 3 - Urgent and routine requests as well as pharmaceutical product returns to the central pharmacy at Hospital Sı´rio-Libaneˆs
before and after implementing the automated medication dispensing system. 2013-2014. Sa˜o Paulo, Brazil.
Conventional dispensing period Automated dispensing period % Reduction p-value
Mean; SD (R$) Mean; SD (USD) Mean; SD (R$) Mean; SD (USD)
Total requests/month
Routine 1,510 (332.60) 649.18 (142.99) 1,279 (385.10) 549.87 (165.53) -15.3 0.17
Urgent 1,519 (220.90) 279.1 (94.97) 431 (88.90) 185.30 (38.22) -71.6 o0.001
Total returns/month 869 (90.50) 373.60 (38.91) 603 (136.30) 259.11 (58.60) -30.60 o0.001
SD = standard deviation.
Table 4 - Activity and time associated with healthcare professional involvement in drug and material management in the Advanced
Assistance Unit of the Hospital Sı´rio-Libaneˆs before and after implementing the automated medication dispensing system, according to
the type of professional. 2013-2014. Sa˜o Paulo, Brazil.
Type of healthcare professional and activities Conventional dispensing period Automated dispensing period Variation
Hours/day Hours/day Hours/day %
Nurse 3.75 0 -3.75 -100
Daily inventory count – controlled substances 2.25 0 -2.25 -100
Adjustments/ corrections of the inventory counts 1.5 0 -1.5 -100
Material supervisor 0.07 0 -0.07 -100
Stock inventory 0.07 0 -0.07 -100
Administrative assistant 5 2 -3 -60
Daily inventory count – drugs 2 0 -2 -100
Daily inventory count – materials 2 0 -2 -100
Item resupply 1 2 1 100
Pharmacy assistant 0 4 4 New
Item resupply 0 1 1 New
Stock inventory 0 3 3 New
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were disregarded because the server was included in the cost of
the device and the user interface software between the central
pharmacy computer system and the ADD system was provi-
ded by the IT service of the HSL.
The 2013 average mid-career salary, considering the gross
monthly salary for a 40-hour weekly workload, was used in
the analysis of healthcare personnel costs as follows: full-
time nurse (R$ 5,869; USD 2,523), administrative/hospitality
assistant (R$ 1,598; USD 687), materials supervisor (R$ 3,526;
USD 1,516), and pharmacy assistant (R$ 1,710; USD 735).
Thus, the reduction in personnel costs totaled R$ 33,598
(USD 14,444) per year during the first year after introducing
the ADD system (Table 5).
For the 5-year period between 2013 and 2017, considering
the salary adjustment based on the Broad National Con-
sumer Price Index between 2013 and 2016 and assuming a
Figure 1 - Drug dispensing before and after implementing the automated dispensing system. Hospital Sı´rio-Libaneˆs, Sa˜o Paulo. Brazil.
2013-2014.
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constant inflation rate of 10% starting in 2016, the reduction
in personnel costs alone totaled R$ 35,480 (USD 15,254) in
2014, R$ 37,690 (USD 16,204) in 2015, R$ 41,942 (USD 18,032)
in 2016, and R$ 44,702 (USD 19,218) in 2017. Thus, the initial
investment would be paid off in 5 years, considering only
personnel savings.
’ DISCUSSION
This investigation is the first study to assess the impact
and costs resulting from implementing automated dispen-
sing systems in Latin America. Implementing this technology
resulted in reduced human resource costs, reduced audit
adjustments regarding drug inclusions and exclusions and
materials inclusions, and a lower number of urgent requests
and product returns to the central pharmacy.
Our results corroborate evidence from developed coun-
tries. Overall human resource time and costs decreased
because of a reduction in nursing time and activity assign-
ment, whereas the work time of pharmacy assistants increa-
sed. A study assessing the implementation of the Pyxiss
system in the United States in 1995 showed a significant
reduction in personnel time related to the use of the ADD
system that resulted in a savings of approximately USD
1 million during a 5-year period for the institution (17). Similar
findings were observed in Spain, where the authors reported
significant increases in clinical activities by pharmacists despite
not having identified significant reductions in medication-
related activities (18). This result might be related to the type of
work attributed to pharmacists and nurses; however, it also
reinforces the finding that the ADD system provides pharma-
cists with more time for other types of clinical work.
Other studies have assessed the economic effect of ADDs
using various methods (19-24). Although those authors
showed a reduction in human resource personnel time and
costs, in the United States, Klein et al. (24) concluded that
this reduction was insufficient because the costs of the
bulk drugs purchased to supply the local ADD system were
higher than those for the same drugs in conventional packag-
ing. However, the drugs in Brazil are included in the ADD
system in unit-dose packaging, which is the same as in
manual systems.
Financial impact studies of ADDs in Spain (21-23) have
indicated a reduction in workload and personnel costs. Poveda
et al. (23) conducted a cost-benefit analysis for the imple-
mentation of 11 ADDs in clinical and surgical intensive and
emergency care units of a university hospital center consisting
of two hospital units in Albacete, Spain. These authors found a
positive cost-benefit ratio (1.95) that favored the implemented
technology. Another publication from the same study that con-
sidered a longer follow-up time reported an estimated h32,390
in annual personnel savings, which resulted in an even higher
cost-benefit ratio (2.19); in that case, the initial investment was
paid off in an estimated 44 months (21).
This result is similar to the findings of our study, which
estimated that the initial investment would be paid off in
5 years or 60 months, considering the reduction in personnel
costs alone.
Although the aforementioned studies consistently indi-
cated the positive economic impact of implementing ADD
systems, a systematic review conducted by the Canadian
Agency for Drugs and Technologies in Health (CADTH) in
2009 to assess the impact of new technologies for drug dis-
pensing and administration regarding their effectiveness,Ta
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cost-effectiveness and budget impact indicated a lack of robust
and high-quality evidence related to ADD systems (25,26).
Since that time, other studies have been performed using
the before-and-after method and were therefore subject
to various biases. A study assessing the economic effect of
implementing an ADD system in a 12-bed resuscitation/
intensive care unit in a French university hospital using the
cash flow method showed reductions in personnel time costs
and drug-storage costs. This cost reduction resulted in an
estimated 5-year savings of h71,586 (19,20).
A more complete and recent analysis of the financial effect
of ADD use in a surgical intensive care unit of a French
university hospital also showed a decrease in drug-related
nursing time and an increase in time dedicated by pharmacy
technicians to the local stock. This study also considered
the decrease in the stock of expired drugs and their respec-
tive costs. The annual cost of the drug stock decreased by
h44,298, and the cost of expired drugs decreased by h14,772.
Using the cash flow method, the study showed that the
overall cash flow was h148,229, and the current net value
of the project 5 years after the initial investment was positive
by h510,404. The authors concluded that the implementa-
tion of ADD systems results in a high return on the initial
investment (19).
The impact of the ADD system on the number and value
of drugs in stock or on expired drugs could not be assessed
in our study. It is worth noting that most institutions use the
model of fully meeting drug needs using the stock of
the ADD system. In the ‘‘hybrid’’ model implemented at the
HSL described above, the peripheral stocks available in the
care units had minimal product types and enough quantity
to minimize financial losses and care failures. The imple-
mentation of the ADD enabled the unit to increase the number
and availability of certain types of products, thereby increasing
process agility.
Packaging, dispensing, and barcoding prescribed items
using an ADD system for prescription items can decrease the
occurrence of ADEs (10). Although a decrease in the number
of ADEs was observed in this study, this decrease was non-
significant. Considering that the number of events that occur-
red during the study period was small, this finding might
result from the low power of the study, which failed to show
an effect on ADEs. However, recently published evidence
indicates controversy regarding the effectiveness of ADD
systems to reduce ADEs related to drug administration. Only
one of 3 systematic reviews published recently showed that
ADD systems effectively reduce the number of ADEs, albeit
modestly (RR=0.72, therefore, 28% effectiveness) (27).
The other studies reported no evidence of decreased ADEs
from using this technology. However, all reviews empha-
sized the small number of studies and the high risk of bias in
the studies reviewed (28).
Thus, similar to most studies on this subject, our study has
several limitations that should be reported. First, the study
was performed retrospectively and using secondary data
available in the hospital. Thus, several outcomes of interest,
including stock control and expired drugs, could not be asses-
sed, as mentioned previously. Furthermore, costs related to the
necessary planning, training and information system adapta-
tions in the stage of preparation for implementing the auto-
mated drug-dispensing system were not included in the cost
analysis.
Despite these limitations, the preliminary results from
this study support the decision to gradually implement the
automated Pyxiss drug-dispensing system in another 16
HSL units starting in 2013.
Previous studies have indicated the widespread use of
ADD systems in several countries. In the United States, a
nationwide survey conducted by the American Society of
Health-Systems Pharmacists in 2011 found that 89% of the
1,401 hospitals assessed used ADD systems (29). A Spanish
study from 2013 on the adoption of safe drug practices
included 36 hospitals and showed that 60.9% of the hospitals
used ADD systems coupled with electronic prescription
systems (30).
In Brazil, reports indicate that this technology has been
gradually incorporated into hospital departments. However,
little evidence on this subject is available in the literature.
Although this study was performed in a tertiary hospital
located in São Paulo (and therefore precludes direct extra-
polations of the results to other hospitals, particularly
Brazilian private hospitals), we believe that our results are
relevant, especially in the Brazilian context, considering the
lack of studies on the subject.
The results from this study contribute to the body of
available evidence showing the positive effect of ADD sys-
tems in reducing healthcare personnel time and costs and
other outcomes of interest related to healthcare services.
Studies assessing the cost and effect of implementing tech-
nologies related to pharmaceutical care in hospital depart-
ments remain scarce in Brazil and should be encouraged,
considering the importance of their results to the decision-
making process. This analysis, in the context of a Brazilian
tertiary private hospital, is useful and may help Brazilian
healthcare decision-makers and managers regarding the use
of this technology.
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